MedPath
Found 196 clinical trials|View Analysis
Sort by:
Need a comprehensive medical report on "HealthPartners Institute"?
Analyze the latest clinical research and treatment options
Summarize scientific findings from medical journals

ACL Reconstruction Rehabilitation With Exercise and Psychological Support

Not Applicable
Not yet recruiting
Conditions
Anterior Cruciate Ligament Reconstruction Rehabilitation
First Posted Date
2025-05-27
Last Posted Date
2025-05-27
Lead Sponsor
HealthPartners Institute
Target Recruit Count
60
Registration Number
NCT06991192

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

Phase 3
Not yet recruiting
Conditions
Type 1 Diabetes
Obesity
Overweight
Interventions
Drug: Placebo
First Posted Date
2025-05-08
Last Posted Date
2025-05-15
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
465
Registration Number
NCT06962280
Locations
🇺🇸

Kaiser Permanente Bonita Medical Offices, Bonita, California, United States

🇺🇸

AMCR Institute, Escondido, California, United States

🇺🇸

Mary & Dick Allen Diabetes Center, Newport Beach, California, United States

and more 78 locations

Utilizing 3D Imaging for Burn Wound Assessment

Recruiting
Conditions
Burn
2nd Degree Burn of the Skin
3rd Degree Burn of the Skin
1st Degree Burn of the Skin
First Posted Date
2025-04-22
Last Posted Date
2025-05-28
Lead Sponsor
HealthPartners Institute
Target Recruit Count
75
Registration Number
NCT06938061
Locations
🇺🇸

Regions Hospital Burn Clinic, Saint Paul, Minnesota, United States

Patient Centered Clinical Decision Support for Hereditary Cancer Syndromes

Not Applicable
Not yet recruiting
Conditions
Hereditary Breast/Ovarian Cancer (brca1, brca2)
Lynch Syndrome
Genetic Variation
HBOC Syndrome
Hereditary Cancer Syndromes
First Posted Date
2025-04-06
Last Posted Date
2025-04-06
Lead Sponsor
HealthPartners Institute
Target Recruit Count
2488
Registration Number
NCT06914726
Locations
🇺🇸

HealthPartners Medical Group, Minneapolis, Minnesota, United States

A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

Phase 3
Recruiting
Conditions
Type 1 Diabetes
Obesity
Overweight
Interventions
Drug: Placebo
First Posted Date
2025-04-06
Last Posted Date
2025-05-25
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
905
Registration Number
NCT06914895
Locations
🇯🇵

Kumamoto Central Hospital - Kumamoto, Kumamoto, Japan

🇺🇸

Sansum Diabetes Research Institute, Goleta, California, United States

🇺🇸

Care Access - Santa Clarita, Santa Clarita, California, United States

and more 293 locations

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

Phase 3
Recruiting
Conditions
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Interventions
First Posted Date
2025-03-05
Last Posted Date
2025-05-22
Lead Sponsor
Amgen
Target Recruit Count
999
Registration Number
NCT06858878
Locations
🇺🇸

Alliance for Multispecialty Research Mobile, Mobile, Alabama, United States

🇺🇸

Gilbert Center for Family Medicine, Gilbert, Arizona, United States

🇺🇸

Desert Clinical Research, Mesa, Arizona, United States

and more 75 locations

TMS Pilot in Early AD II

Not Applicable
Conditions
Alzheimer Disease
First Posted Date
2025-02-10
Last Posted Date
2025-02-10
Lead Sponsor
HealthPartners Institute
Target Recruit Count
6
Registration Number
NCT06817902
Locations
🇺🇸

HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States

The Effect of the Safe and Sound Protocol on Depression and Anxiety Symptoms

Not Applicable
Not yet recruiting
Conditions
Anxiety
Depression
First Posted Date
2024-11-22
Last Posted Date
2025-04-09
Lead Sponsor
HealthPartners Institute
Target Recruit Count
120
Registration Number
NCT06701578
Locations
🇺🇸

Regions Hospital, Saint Paul, Minnesota, United States

Continuous Glucose Monitoring Using a New Subcutaneous Insulin Protocol for Mild to Moderate Diabetic Ketoacidosis

Not Applicable
Not yet recruiting
Conditions
Diabetic Ketoacidosis
Hyperglycemia
First Posted Date
2024-11-18
Last Posted Date
2025-02-25
Lead Sponsor
HealthPartners Institute
Target Recruit Count
80
Registration Number
NCT06693115
Locations
🇺🇸

Regions Hospital, Saint Paul, Minnesota, United States

A Randomized Trial of Medical Cannabis in Patients With Advanced Pancreatic Cancer

Phase 2
Recruiting
Conditions
Pancreatic Ductal Adenocarcinoma (PDAC)
Interventions
First Posted Date
2024-09-20
Last Posted Date
2024-10-01
Lead Sponsor
HealthPartners Institute
Target Recruit Count
32
Registration Number
NCT06605430
Locations
🇺🇸

HealthPartners Cancer Research Center, Saint Louis Park, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath